Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Amended and Restated Certificate of Incorporation
- 3.3 Bylaws
- 3.4 Form of Amended and Restated Bylaws
- 4.1 Form of Common Stock Certificate
- 10.1 Form of Indemnity Agreement
- 10.2 2009 Equity Incentive Plan and Form of Stock Option Grant Notice
- 10.3 2012 Equity Incentive Plan and Form of Stock Option Agreement
- 10.4 Non-employee Director Compensation Policy
- 10.5 2012 Employee Stock Purchase Plan
- 10.6 Amended and Restated Employment Agreement
- 10.7 Amended and Restated Employment Agreement
- 10.8 Employment Agreement
- 10.9 Lease
- 10.10 First Amendment to Lease
- 10.11 Second Amendment to Lease
- 10.12 Third Amendment to Lease
- 10.13 Founding Investor Rights Agreement
- 10.14 Amendment Number One to the Founding Investor Rights Agreement
- 10.15 Amendment Number Two to the Founding Investor Rights Agreement
- 10.16 Investor Rights Agreement
- 10.17 Amended and Restated License and Collaboration Agreement
- 10.18 Amendment Number One to the Amended & Restated License & Collaboration Agreement
- 10.19 Amendment Number Two to the Amended & Restated License & Collaboration Agreement
- 10.20 Product Development and Commercialization Agreement
- 10.21 Amendment #1 to the Product Developement and Commercialization Agreement
- 10.22 Amendment #2 to the Product Developement and Commercialization Agreement
- 10.23 Amendment #3 to the Product Developement and Commercialization Agreement
- 10.24 Exclusive License and Nonexclusive Option Agreement
- 10.25 Co-exclusive License Agreement
- 10.26 Assignment Agreement
- 10.27 License Agreement
- 10.28 Amended and Restated License Agreement
- 10.29 Nyu-regulus License Agreement
- 10.30 Exclusive Patent License Agreement
- 10.31 Amended and Restated Collaboration and License Agreement
- 10.32 Non-exclusive Technology Alliance and Option Agreement
- 10.33 Amended and Restated Convertible Promissory Note No. 1
- 10.34 Amended and Restated Convertible Promissory Note No. 2
- 10.35 Amendment #4 to the Product Development and Commercialization Agreement
- 10.36 Amendment Number Three to the Founding Investor Rights Agreement
- 10.37 Collaboration and License Agreement
- 10.38 Common Stock Purchase Agreement
- 10.39 Collaboration and License Agreement
- 10.40 Note Purchase Agreement
- 10.41 Convertible Promissory Note
- 23.1 Consent of Independent Registered Public Accounting Firm
- 99.1 Confidential Draft Registration Statement #1
- 99.2 Confidential Draft Registration Statement #2
RGLS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and the use of our report dated February 9, 2012, except for the retrospective adoption of amendments to the accounting standard relating to the reporting and display of comprehensive loss as described in Note 1, as to which the date is June 21, 2012, in the Registration Statement on Form S-1 and related Prospectus of Regulus Therapeutics Inc. dated August 17, 2012.
/s/ Ernst & Young LLP
San Diego, California
August 17, 2012